Peer Review History

Original SubmissionMay 6, 2021
Decision Letter - Yann Benetreau, Editor

PONE-D-21-14840

Impact of the COVID-19 Pandemic on Psychological Distress and Biological Rhythm in China’s General Population: A Path Analysis Model

PLOS ONE

Dear Dr. Ma,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address all reviewer comments. However, please note that you are not required to cite all references listed in the reviews. Please consider whether they are relevant to your manuscript; you may choose to cite them or not.

Please submit your revised manuscript by Jan 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Yours sincerely,

Yann Benetreau, PhD

Senior Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent.

3. Please complete all items on the Clinical Studies Checklist that are relevant for your submission, by following this link: http://journals.plos.org/plosone/s/file?id=dc11/PLOSOne_Clinical_Studies_Checklist.docx (Contact us at plosone@plos.org if you cannot access the document.) There may be overlap between the checklist items and other queries listed below; please address any duplicated queries both in your response email and on the checklist itself. Upload the completed Clinical Studies Checklist as file type “Other” when you re-submit your manuscript. This document is for internal journal use only and will not be published if your article is accepted. The requested information will help us to assess whether your submission complies with PLOS ONE’s policies and adheres to applicable reporting standards. Note that your manuscript may be rejected if you provide incomplete or inadequate responses to the checklist questions and that changing the ‘Section/Category’ of your article does not affect this requirement.

4. Please change "female” or "male" to "woman” or "man" as appropriate, when used as a noun (see for instance https://apastyle.apa.org/style-grammar-guidelines/bias-free-language/gender).

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have the following comments for the authors to address. I am happy to review this paper again.

1) Under the Introduction, the authors stated "Social distancing, self-isolation and travel restrictions have led to a reduced workforce across all economic sectors and caused many jobs to be lost'". Please discuss the impact of social distancing, lockdown and facemask use on mental health:

Social distancing on mental health:

Impact of COVID-19 on Economic Well-Being and Quality of Life of the Vietnamese During the National Social Distancing. Front Psychol. 2020 Sep 11;11:565153. doi: 10.3389/fpsyg.2020.565153. PMID: 33041928; PMCID: PMC7518066.

Lockdown on mental health:

Anxiety and Depression Among People Under the Nationwide Partial Lockdown in Vietnam. Front Public Health. 2020;8:589359. Published 2020 Oct 29. doi:10.3389/fpubh.2020.589359

Facemask on mental health:

The Association Between Physical and Mental Health and Face Mask Use During the COVID-19 Pandemic: A Comparison of Two Countries With Different Views and Practices. Front Psychiatry. 2020;11:569981. Published 2020 Sep 9. doi:10.3389/fpsyt.2020.569981

2) Under the Introduction, the authors stated "Approximately 10%-30% general population were much concerned with being infected when an influenza outbreak occurred [10]." It is more appropriate to discuss the impact on general population during the pandemic instead of influenza. The following is a multinational study and its finding worth mentioning:

The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia. PLoS One. 2021 Feb 11;16(2):e0246824. doi: 10.1371/journal.pone.0246824. PMID: 33571297.

3) Under the discussion, the authors stated "Nevertheless, most previous studies reported that females suffer from more somatization symptoms than males and are more vulnerable to psychological distress [32, 34]." Reference 32 and 34 are not from China. Please check with studies from China whether they report similar or different finding:

A Longitudinal Study on the Mental Health of General Population during the COVID-19 Epidemic in China [published online ahead of print, 2020 Apr 13]. Brain Behav Immun. 2020; S0889-1591(20)30511-0. doi:10.1016/j.bbi.2020.04.028

4) Under the discussion, the authors should mention the relationship between physical or somatic symptoms and mental health based on the following study: "A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans. Sci Rep 11, 6481 (2021). " ext-link-type="uri" xlink:type="simple">https://doi.org/10.1038/s41598-021-85943-7"

5) Please discuss how to reduce somatic symptoms. I recommend Internet cognitive behavior therapy (iCBT) as it will reduce face to face contact and improve mental well being:

The most evidence-based treatment is cognitive behaviour therapy (CBT), especially Internet CBT that can prevent the spread of infection during the pandemic. Please refer to the following studies:

Use of Cognitive Behavior Therapy (CBT) to treat psychiatric symptoms during COVID-19:

Mental Health Strategies to Combat the Psychological Impact of COVID-19 Beyond Paranoia and Panic. Ann Acad Med Singapore. 2020;49(3):155‐160.

Cost-effectiveness of iCBT:

Moodle: The cost effective solution for internet cognitive behavioral therapy (I-CBT) interventions. Technol Health Care. 2017;25(1):163-165. doi: 10.3233/THC-161261. PMID: 27689560.

Internet CBT can treat psychiatric symptoms such as insomnia:

Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med. 2020 Aug 26;75:315-325. doi: 10.1016/j.sleep.2020.08.020. Epub ahead of print. PMID: 32950013.

6) Please discuss how somatic symptoms may affect COVID-19 vaccine as people may think somatic symptoms as side effects of vaccines. Please comment on the following vaccine study and how somatic symptoms may affect attitude towards COVID-19 vaccine:

Attitudes toward COVID-19 vaccination and willingness to pay: Comparison of people with and without mental disorders in China. BJPsych Open, 7(5), E146. doi:10.1192/bjo.2021.979

Reviewer #2: The article is well-written and provides some interesting insight on the psychological impact of COVID-19, with a particular attention on gender differences.

The references are provided to a satisfying extent. Finally, the findings support the authors' conclusions and the sample size is totally reliable.

I just have a few concerns as regards the SEM/Path analysis. I wasn't able to grasp whether the analysis at hand is a proper SEM (therefore, with at least 1 latent variable) or a mere path analysis wherein all the variables are observed and we can assume no error. There seems to be some confusion about this aspect and I would definitely recommend further specifications on this issue.

In my opinion, this is the most critical point of the article; thus, it should be taken in serious consideration by the authors.

One last point: I am wondering whether the authors have considered to perform a multigroup SEM to see how the paths work for the two genders separately; i.e., whether some of the paths are significantly stronger for one of the genders.

I hereby attach a pdf file with 19 comments on several other points of the article.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-21-14840.pdf
Revision 1

Dear editor. Yann Benetreau,  

Re. Resubmission of PONE-D-21-14840, “Impact of the COVID-19 Pandemic on Psychological Distress and Biological Rhythm in China’s General Population: A Path Analysis Model”

Thank you for your action letter with the enclosed reviewers’ comments on our paper and your invitation to resubmit. We are grateful for the reviewers’ constructive comments. Our point-by-point response to the reviewers’ comments is immediately below this letter, and we have highlighted changes in red in the revised manuscript. We hope that by addressing the issues raised by the reviewers, the revised manuscript has been significantly improved and acceptable for publication in PLOS ONE. Should further revision be needed, please let us know.

Thank you very much for your time and consideration. We are looking forward to hearing from you.

Sincerely,

Xiaohong Ma

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Abraham Salinas-Miranda, Editor

PONE-D-21-14840R1Impact of the COVID-19 Pandemic on Psychological Distress and Biological Rhythm in China’s General Population: A Path Analysis ModelPLOS ONE

Dear Dr. Ma,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Academic Editor: Thank you for your revision. One of the reviewers found minor issues that need to be fixed before the paper is published. Please address them and resubmit. 

Please submit your revised manuscript by Jun 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Abraham Salinas-Miranda, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I recommend publication and thanks for your amendments. This is a very good paper to be published and benefits the academia.

Reviewer #3: The authors sought to assess the influence of gender on social support, information preference, biological rhythm, and psychological distress during the COVID-19 pandemic. This addresses the gap of limited studies on the influence of gender on psychosomatic outcomes in the context of the COVID-19 pandemic. The authors used path analysis to assess the primary outcome of somatization. Overall, they found gender differences in factors predicting somatization and the important role of social support as a protective factor. Because of the paucity of literature on the influence of gender on somatization in the Chinese population in the context of COVID-19, this study helps to address this literature gap.

Overall

• This is a sound paper however there are numerous grammatical errors and areas where the authors sometimes switch between tenses (i.e. switch between present tense and past tense) that will need to be addressed.

• Standardized coefficients are not presented.

Introduction

1. Since you cited Chinese studies, the sentence on influenza is not needed: “Approximately 10%-30% general population were much concerned with being infected when there was an influenza outbreak[11]”

2. Typos in this sentence: “Moreover, a survey based on seven middle income countries in the general population showed high risk factors on mental health during the COVID-19 pandemic which related to single or separated status, high education level, and age 30 years [12].”

3. This sentence is confusing: “Furthermore, social media of unreliable sources usually provide much ambiguous epidemic information, and overloaded information may cause psychological distress in turn [16]. For example, while facemask wearing is a positive precaution, it still goes through social stigma, arousing mixed opinion and contradictory messaging from the media, which all lead to public fear and confusion [17].” Should it read like this instead? “Furthermore, social media using unreliable sources, usually provide ambiguous epidemic information, and information overload may cause psychological distress in turn [16]. For example, while facemask wearing is a positive precaution, its use brings about social stigma, arousing mixed opinion and contradictory messaging from the media, which all lead to public fear and confusion [17].” Please clarify.

4. Remove “etc” from the sentence: “Staying up late, getting up late, and lying in bed during non-sleeping …, social activities, etc. and aggravating people's physical and psychological distress in the meantime.”

Methods

1. Typos with APPS (make it lowercase) and ‘research’ is plural: “2) Both negative and positive media information. This question was designed based on some previous research which aimed to reflect the preference of different respondents for the magnanimity of media information on cellphone social apps or television[16, 20, 32, 33].”

2. The authors mention aiming to study possible causal relationships. However, causality cannot be assessed in a cross-sectional study. Please revise. Also correction with grammar: “ Finally, aiming to study the possible causal relationship…path analysis to test the relationship among interrelated study variables in a hypothesized model.”

Results

1. For Chi square the authors use both lower “x2” and upper case “X2”. Please be consistent and use upper case X2 throughout manuscript. Similar suggestion for “p values”. Use P or p to match how it is recommended by the journal. ‘p’ for values of p0.001.

2. Correction: (S1 Table shows the effect size of study variables…)

3. The authors go back and forth between using “men”, “women”, “males”, and “females”. Please be consistent and use terms appropriately.

4. It is suggested to remove the word “obviously” from the manuscript.

5. Again, the mention of exploring causality is mentioned and is not possible for a cross-sectional study.

6. Please report standardized coefficients and R2 values for the final model in table.

Discussion

1. Did the authors mean “In this cross-sectional study involving 3,237 participants, we found significant differences in social support total scores and…”?

2. Again, the authors switch between using “men”, “women”, “males”, and “females”. Please address this.

3. Correction: “Third,for unmarried or single men who lived alone, self-isolation may be a big challenge…be confused by epidemic information and experience increased fear of the COVID-19 pandemic.”

4. Correction: “Besides, the acceptance of the COVID-19 vaccine is also affected by…”

5. This sentence is confusing: “To some extent, hesitation in front of vaccine can be increased by rumors and stigmas.” Are the authors trying to say that rumors and stigma increase an individual’s hesitancy for vaccination uptake? Please reword for clarity.

6. Please use correct in-text citation based on journal style to cite: “Therefore, as Wong L P emphasized, the dissemination of epidemic information…”

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Dear Reviewers,

We apologize for the grammatical errors that still persist. We have read the comments carefully and prepared one-by-one replies in Response to Reviewers. And we hope this version is better and has addressed your concern regarding language. All the changes were marked in red in Revised Manuscript with Track Changes.

Thank you very much for your time and consideration. We are looking forward to hearing from you.

Sincerely,

Xiaohong Ma

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Abraham Salinas-Miranda, Editor

Impact of the COVID-19 Pandemic on Psychological Distress and Biological Rhythm in China’s General Population: A Path Analysis Model

PONE-D-21-14840R2

Dear Dr. Ma,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Abraham Salinas-Miranda, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

As Academic Editor, I have found the authors' responses adequate for the reviewers' comments. My recommendation is to accept for publication.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Abraham Salinas-Miranda, Editor

PONE-D-21-14840R2

Impact of the COVID-19 pandemic on psychological distress and biological rhythm in China’s general population: A path analysis model

Dear Dr. Ma:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Abraham Salinas-Miranda

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .